Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Laryngoscopes Market is poised to grow at a CAGR of 5.4% by 2033, The rise in the use of laryngoscopes in airway management driving the laryngoscope industry growth Says Future Market Insights, Inc.

Published

on

<!– Name:DistributionId Value:8798840 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1095645 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:e325bb09-69d3-4e97-bab5-5f00caf572f7 –>

DUBAI, United Arab Emirates, March 30, 2023 (GLOBE NEWSWIRE) — The Laryngoscopes Market is expected to thrive at a CAGR of 5.4% between 2023 and 2033. The market is anticipated to cross a market share of US$ 601.6 million by 2033 while it is likely to be valued at US$ 355.1 million in 2023.

  • The higher demand for advanced flexible video laryngoscopes coupled with the increased government budget for healthcare diagnostics is garnering the sales of Laryngoscopes solutions.
  • Increasing chronic patients such as patients suffering from cancer and other respiratory or throat-related diseases are garnering market growth.
  • Private healthcare systems adopting disease-specific Laryngoscopes solutions along with the expanding healthcare infrastructure in Asian Economies such as India and China drive the market.
  • With the growing health awareness, end users go through several tests that include different ENT tests. Furthermore, expanding research facilities are thriving in the sales of Laryngoscopes solutions.

Get a PDF Sample with Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12786

Key Points

  1. The United States is likely to lead the Laryngoscopes market in terms of market share. The market is expected to thrive at a leading CAGR of 5.6% between 2023 and 2033. The market growth is attributed to rapidly growing cases of throat cancer and other respiratory diseases. The regional market is likely to cross a value of US$ 199.2 million by 2033.
  2. The China Laryngoscopes market is leading the Laryngoscopes market in terms of CAGR. The regional growth is attributed to the increase in private hospitals and diagnostic centers. Also, the booming healthcare infrastructure is flourishing the sales of Laryngoscopes solutions in the region. The regional market is anticipated to thrive at a CAGR of 8.2% during the forecast period while it is expected to hold a value of US$ 58.5 million by 2033.
  3. The flexible Laryngoscopes segment is likely to thrive in the product size category as it strives at a CAGR of 5.7% during the forecast period. The growth is attributed to factors like acute imaging and better diagnosis.
  4. The hospital segment is expected to top the end-user category as it thrives at a CAGR of 5.4% between 2023 and 2033.

Competitive Landscape

The key vendors focus on experimenting with newer technology such as Artificial Intelligence and high-end camera settings. Furthermore, technological integration with machine learning and robotics are some elements on which vendors focus the most. Key competitors also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel. The key players in the market are KARL STORZ GmbH & Co, Flexicare Medical, NOVAMED USA, Penlon Limited, Ambu A/S, Rudolf Riester GmbH, Medtronic plc., Clarus Medical LLC, BOMImed, Propper Manufacturing Co. Inc., Teleflex Incorporated, Verathon Inc, Venner Medical (Germany) GmbH.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12786

Recent Market Developments

  • Rudolf Riester GmbH has introduced different types of laryngoscopes like ri-integral, ri-modul, and ri-dispo (Disposable). Other than this, the laryngoscopes include fiberoptic, standard, and disposable laryngoscopes with LED/Li-ion technology.
  • Teleflex Incorporated has developed its Rusch Polaris single-use fiber optic laryngoscope blades. These blades are of wide range and come with a low-profile blade design. The finishing used on the blade is matte so that it can reduce the light reflection.

Key Segments

Laryngoscopes Market by Product Type:

  • Rigid Laryngoscopes
  • Flexible Laryngoscopes
    • Video Laryngoscopes
    • Fiber Laryngoscopes

Laryngoscopes Market by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

Laryngoscopes Market by Usability:

  • Reusable Laryngoscopes
  • Disposable Laryngoscopes

For more Report Customization, connect with us @ https://www.futuremarketinsights.com/customization-available/rep-gb-12786

Table of Content
1. Executive Summary | Laryngoscope Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

Get Full Access @ https://www.futuremarketinsights.com/reports/laryngoscopes-market

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Medical Coding Market Size: The medical coding market is estimated to secure a valuation of US$ 6.7 billion in 2023 and is estimated to rise to US$ 15.3 billion by 2033, concludes Future Market Insights. The market is anticipated at a CAGR of 8.6% during the 2023 to 2033.

Heparin Market Share: The heparin market is estimated to secure a valuation of US$ 6.2 billion in 2023 and is estimated to rise to US$ 9.2 billion by 2033, as per Future Market Insights. The market is anticipated at a CAGR of 4%.

ENT endoscopy Market Demand: As per Future Market Insights, the ENT endoscopy market is estimated to secure a valuation of US$ 8.7 billion in 2023 and is estimated to rise to US$ 16.3 billion by 2033. The market is anticipated to grow at a CAGR of 6.5% during the forecast period.

Bioprocess Validation Market Opportunity: As per the current market research conducted by FMI, the global bioprocess validation market is expected to record a CAGR of 9.20% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 449.03 million. By 2033, the valuation is anticipated to reach US$ 996.29 million.

Dental Compressors Market Growth: The dental compressors market is registering a valuation of US$ 378.75 million in 2023. The market is likely to rise to US$ 529.12 million by 2033. The market is expected to secure a CAGR of 3.4% during the forecast period.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: 
Future Market Insights, Inc.
1602-6 Jumeirah Bay X2 Tower, 
Plot No: JLT-PH2-X2A, 
Jumeirah Lakes Towers, Dubai, 
United Arab Emirates 
For Sales Enquiries: [email protected] 
 LinkedInTwitterBlogs | YouTube

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

JupiterOne and watchTowr announce partnership to protect business critical assets with broad exposure management capabilities

Published

on

jupiterone-and-watchtowr-announce-partnership-to-protect-business-critical-assets-with-broad-exposure-management-capabilities

SINGAPORE, May 2, 2024 /PRNewswire/ — watchTowr, a leader in external attack surface management (EASM) technology and fuelled by watchTowr Labs, a renowned vulnerability R&D capability, has formed a strategic partnership with JupiterOne. JupiterOne is a leader in cyber asset attack surface management (CAASM) technology. This collaboration enables customers to rapidly prioritize emerging threats within their constantly changing environments, focusing on fixing the most critical risks impacting their business, which enables an end-to-end continuous threat exposure management process (CTEM).

Over 28,000 CVE records were published in 2023; a figure that is expected to increase as attackers shorten the time from known vulnerability to exploit, reducing it from weeks to days. JupiterOne and watchTowr’s integrated solution empowers enterprises to discover their most critical and exploitable vulnerabilities, prioritize them with asset context based on business impact and receive an actionable remediation plan to improve security posture.
This partnership enables a complete continuous threat exposure management program, addressing the full spectrum of cyber risk management. The fully integrated solution provides continuous monitoring and assessment of both internal and external digital assets, allowing for prioritization and effective threat mitigation for a business’s most critical assets. “Our partnership with watchTowr is a game-changer” said Forte. “Combining our data aggregation with real-time asset discovery and automated security testing allows us to offer a unique, all-encompassing approach to exposure management.”
Benjamin Harris, CEO, watchTowr, said, “While the number of reported vulnerabilities continues to rise, the vulnerabilities that matter – in mission-critical, key systems – have exploded at an alarming rate. This reality, combined with the significant shift in speed by attackers to weaponize vulnerabilities – the ability to validate exploitability and prioritise actions based on real business risk has never been more vital. We’re excited to join forces with JupiterOne to give security teams around the globe this much-needed end-to-end capability.”
About JupiterOne:
JupiterOne is a cybersecurity startup delivering powerful software solutions to companies across all industries, providing deep insights to cyber assets and the relationships between, empowering security professionals to have true knowledge and ownership of their attack surfaces.
About watchTowr: 
watchTowr is a global cybersecurity technology company, built by former adversaries.
watchTowr’s world-class External Attack Surface Management and Continuous Automated Red Teaming technology is informed by years of experience compromising some of the world’s most targeted organisations and utilised by Fortune 500, financial services and critical infrastructure providers every day.
Photo – https://mma.prnewswire.com/media/2401497/watchTowr_JupiterOne.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jupiterone-and-watchtowr-announce-partnership-to-protect-business-critical-assets-with-broad-exposure-management-capabilities-302132392.html

Continue Reading

Artificial Intelligence

Clarivate Declares Dividend on Mandatory Convertible Preferred Shares

Published

on

clarivate-declares-dividend-on-mandatory-convertible-preferred-shares

LONDON, May 1, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT; CLVT PR A) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares (the “Preferred Shares”), payable in cash on June 3, 2024 to shareholders of record at the close of business on May 15, 2024.

On the mandatory conversion date, which is scheduled to occur on June 3, 2024, each Preferred Share will automatically and mandatorily convert into a number of ordinary shares of Clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price (“VWAP”) of Clarivate’s ordinary shares over a 30-trading day period that begins on, and includes, April 18, 2024 and is scheduled to end on, and include, May 30, 2024 (the “valuation period”). If such VWAP is (i) greater than $31.20, then the mandatory conversion rate will be 3.2052 ordinary shares of Clarivate per Preferred Share, (ii) less than or equal to $31.20 but equal to or greater than $26.00, then the mandatory conversion rate will be a number of ordinary shares of Clarivate per Preferred Share equal to $100.00 divided by such VWAP and (iii) less than $26.00, then the mandatory conversion rate will be 3.8462 ordinary shares of Clarivate per Preferred Share. The mandatory conversion rate will be announced following the end of the valuation period. The above description of the terms of the Preferred Shares is not complete and is subject to, and qualified in its entirety by reference to, the “Statement of Rights” for the Preferred Shares, which is filed as Exhibit 3.2 to Clarivate’s annual report on Form 10-K for the fiscal year ended December 31, 2023.
Cautionary Note Regarding Forward-Looking Statements
This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also adversely affect our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-declares-dividend-on-mandatory-convertible-preferred-shares-302133633.html

Continue Reading

Artificial Intelligence

CGTN: 3rd CMG Forum in Beijing discusses AI development

Published

on

cgtn:-3rd-cmg-forum-in-beijing-discusses-ai-development

BEIJING, May 1, 2024 /PRNewswire/ — Focusing on the development of AI, the third CMG Forum was held on Monday in Beijing.

Li Shulei, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and the head of the Publicity Department of the CPC Central Committee, attended the opening of the event and delivered a speech.
Guests at the forum stressed the role of media in promoting the innovative application of AI as well as its governance.
Efforts should also be made to boost the development of AI in creating positive, healthy, diverse and high-quality content, so that AI can become a force for good and benefit mankind, they agreed.
They also called on media to accelerate intelligent transformation and help bridge international exchanges and cooperation on the governance of AI to facilitate its healthy, orderly and safe development.
Hosted by China Media Group (CMG), the forum attracted more than 200 participants from international organizations, media, think tanks and multinational companies.
“Innovation and breakthroughs in science and technology not only guide the development and progress of human civilization, but also bring uncertainty to the changing world,” said Shen Haixiong, vice minister of the Publicity Department of the CPC Central Committee and president of CMG. He called for efforts to jointly create valuable and responsible artificial intelligence.
AI technology is affecting every aspect of our lives. Thomas Bach, president of the International Olympic Committee (IOC), stated in a video speech that CMG has always been a partner of the IOC, bringing the charm of the Olympic Games to hundreds of millions of Chinese viewers. He said the IOC invites CMG to work together for the creation of a future with the application of AI in Olympic sports.
“From ancient inventions such as silk, printing and the compass to modern technological advances such as robotics, telecommunications and green technology, China has always been committed to innovation and creation,” said Daren Tang, director general of the World Intellectual Property Organization (WIPO). He said WIPO pays close attention to ensuring a balance between the opportunities and risks of artificial intelligence and is committed to strengthening cooperation to ensure that artificial intelligence is properly used.
https://news.cgtn.com/news/2024-04-30/3rd-CMG-Forum-in-Beijing-discusses-AI-development-1tdDcXvCexG/p.html

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-3rd-cmg-forum-in-beijing-discusses-ai-development-302133410.html

Continue Reading

Trending